Semaglutide is a peptide, a synthetic hormone, which mimics the GLP-1 hormone your body already produces to tell our brains were full and dont need to eat anymore
HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS
Need for Comprehensive Support: The findings highlight the growing interest in expanding GLP-1 use beyond weight loss to address complex health conditions, though providers emphasize the need for training and patient monitoring to support this shift
Since GLP-1 medications are known to reduce gut motility, scientists have wondered whether they could play a role in causing SIBO or IMO
This helps identify contributing factors and allows your provider to determine whether GLP-1 therapy may be appropriate for your goals
Nobels A, van Marcke C, Jordan BF, Van Hul M, Cani PD